
Fluid Pharma and Mikart Partnership: ODT microparticles improve acceptability in patients with Dysphagia
Sponsored Content
Sustained Release Orally Disintegrating Tablets (ODTs) Comprising Coated Microparticles to Improve Acceptability in Patients with Dysphagia

